Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Medical Eligibility Required Semaglutide and Tirzepatide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Tirzepatide or Semaglutide
Pyrroloquinoline Quinone (PQQ) has potent antioxidant effects that reduce oxidative stress and support healthy aging
People can lose weight on all three of these medications even though Mounjaro and Ozempic both only have FDA approval for diabetes and blood sugar management
Prefer a doctor-guided approach rather than self-directed weight loss strategies
